RESULTS	Cox regression analysis for progression-free survival identified concomitant treatment ( P = .003 ) , Radiation Therapy Oncology Group ( RTOG ) stage III grouping ( P < .0001 ) , performance status ( P = .0002 ) , concomitant treatment ( P = .003 ) , and treating institution ( P = .006 ) as significant .\